{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:55:09Z","timestamp":1779245709078,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98922-z","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:39:48Z","timestamp":1747906788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cystathionine gamma-lyase as an inflammatory factor and its link with immune inflammation in hepatitis B virus-related liver disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Chao","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianning","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghua","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"98922_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA. Cancer J. Clin."},{"key":"98922_CR2","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.27969","volume":"62","author":"C de Martel","year":"2015","unstructured":"de Martel, C., Maucort-Boulch, D., Plummer, M. & Franceschi, S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62, 1190\u20131200. https:\/\/doi.org\/10.1002\/hep.27969 (2015).","journal-title":"Hepatology"},{"key":"98922_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1473-3099(15)00218-2","volume":"16","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21\u201349 years in rural China: A population-based, cross-sectional study. Lancet Infect. Dis. 16, 80\u201386. https:\/\/doi.org\/10.1016\/S1473-3099(15)00218-2 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"98922_CR4","first-page":"113","volume":"27","author":"J Huang","year":"2022","unstructured":"Huang, J., Qiu, G. & Zeng, Y. Advances in surgical treatment of hepatocellular carcinoma. Surg. Theory Pract. 27, 113\u2013118 (2022).","journal-title":"Surg. Theory Pract."},{"key":"98922_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370\u2013398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021 (2017).","journal-title":"J. Hepatol."},{"key":"98922_CR6","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560\u20131599. https:\/\/doi.org\/10.1002\/hep.29800 (2018).","journal-title":"Hepatology"},{"key":"98922_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5604\/17322693.1085372","volume":"68","author":"H Jurkowska","year":"2014","unstructured":"Jurkowska, H., Kaczor-Kami\u0144ska, M., Bronowicka-Adamska, P. & Wr\u00f3bel, M. Cystathionine \u03b3-lyase. Postepy. Hig. Med. Dosw. 68, 1\u20139. https:\/\/doi.org\/10.5604\/17322693.1085372 (2014).","journal-title":"Postepy. Hig. Med. Dosw."},{"key":"98922_CR8","doi-asserted-by":"publisher","first-page":"20180033","DOI":"10.1515\/dmpt-2018-0033","volume":"34","author":"E Giannakopoulou","year":"2019","unstructured":"Giannakopoulou, E. et al. Association study of the CTH 1364 G>T polymorphism with coronary artery disease in the Greek population. Drug. Metab. Pers. Ther. 34, 20180033. https:\/\/doi.org\/10.1515\/dmpt-2018-0033 (2019).","journal-title":"Drug. Metab. Pers. Ther."},{"key":"98922_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cellsig.2012.02.003","volume":"24","author":"P Yin","year":"2012","unstructured":"Yin, P. et al. Sp1 is involved in regulation of cystathionine \u03b3-lyase gene expression and biological function by PI3K\/Akt pathway in human hepatocellular carcinoma cell lines. Cell Signal 24, 1229\u20131240. https:\/\/doi.org\/10.1016\/j.cellsig.2012.02.003 (2012).","journal-title":"Cell Signal"},{"key":"98922_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.neuro.26.041002.131047","volume":"26","author":"D Boehning","year":"2003","unstructured":"Boehning, D. & Snyder, S. H. Novel neural modulators. Annu. Rev. Neurosci. 26, 105\u2013131. https:\/\/doi.org\/10.1146\/annurev.neuro.26.041002.131047 (2003).","journal-title":"Annu. Rev. Neurosci."},{"key":"98922_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/science.1162667","volume":"322","author":"G Yang","year":"2008","unstructured":"Yang, G. et al. H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase. Science 322, 587\u2013590. https:\/\/doi.org\/10.1126\/science.1162667 (2008).","journal-title":"Science"},{"key":"98922_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pain.2007.01.026","volume":"132","author":"A Kawabata","year":"2007","unstructured":"Kawabata, A. et al. Hydrogen sulfide as a novel nociceptive messenger. Pain 132, 74\u201381. https:\/\/doi.org\/10.1016\/j.pain.2007.01.026 (2007).","journal-title":"Pain"},{"key":"98922_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.bbrc.2005.06.021","volume":"333","author":"M Yusuf","year":"2005","unstructured":"Yusuf, M. et al. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem. Biophys. Res. Commun. 333, 1146\u20131152. https:\/\/doi.org\/10.1016\/j.bbrc.2005.06.021 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"98922_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.coph.2005.10.007","volume":"6","author":"L Li","year":"2006","unstructured":"Li, L., Bhatia, M. & Moore, P. K. Hydrogen sulphide\u2013a novel mediator of inflammation?. Curr. Opin. Pharmacol. 6, 125\u2013129. https:\/\/doi.org\/10.1016\/j.coph.2005.10.007 (2006).","journal-title":"Curr. Opin. Pharmacol."},{"key":"98922_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardiores.2007.05.026","volume":"76","author":"WJ Cai","year":"2007","unstructured":"Cai, W. J. et al. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc. Res. 76, 29\u201340. https:\/\/doi.org\/10.1016\/j.cardiores.2007.05.026 (2007).","journal-title":"Cardiovasc. Res."},{"key":"98922_CR16","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.21873\/anticanres.15225","volume":"41","author":"E Ozluk","year":"2021","unstructured":"Ozluk, E. et al. Cystathionine gamma-lyase is increased in testicular seminomas, embryonal, and yolk sac tumors. Anticancer Res. 41, 4211\u20134214. https:\/\/doi.org\/10.21873\/anticanres.15225 (2021).","journal-title":"Anticancer Res."},{"key":"98922_CR17","doi-asserted-by":"publisher","first-page":"e45986","DOI":"10.15252\/embr.201845986","volume":"20","author":"YH Wang","year":"2019","unstructured":"Wang, Y. H. et al. Dysregulation of cystathionine \u03b3-lyase promotes prostate cancer progression and metastasis. EMBO. Rep. 20, e45986. https:\/\/doi.org\/10.15252\/embr.201845986 (2019).","journal-title":"EMBO. Rep."},{"key":"98922_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.18388\/abp.2016_1394","volume":"64","author":"P Bronowicka-Adamska","year":"2017","unstructured":"Bronowicka-Adamska, P., Bentke, A. & Wr\u00f3bel, M. Hydrogen sulfide generation from l-cysteine in the human glioblastoma-astrocytoma U-87 MG and neuroblastoma SHSY5Y cell lines. Acta. Biochim. Pol. 64, 171\u2013176. https:\/\/doi.org\/10.18388\/abp.2016_1394 (2017).","journal-title":"Acta. Biochim. Pol."},{"key":"98922_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill, F. & Mantovani, A. Inflammation and cancer: Back to Virchow?. Lancet 357, 539\u2013545. https:\/\/doi.org\/10.1016\/S0140-6736(00)04046-0 (2001).","journal-title":"Lancet"},{"key":"98922_CR20","first-page":"65","volume":"57","author":"F Okada","year":"2014","unstructured":"Okada, F. Inflammation-related carcinogenesis: Current findings in epidemiological trends, causes and mechanisms. Yonago Acta. Med. 57, 65\u201372 (2014).","journal-title":"Yonago Acta. Med."},{"key":"98922_CR21","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2147\/OTT.S68084","volume":"7","author":"JF Feng","year":"2014","unstructured":"Feng, J. F., Huang, Y. & Chen, Q. X. A new inflammation index is useful for patients with esophageal squamous cell carcinoma. Onco. Targets Ther. 7, 1811\u20131815. https:\/\/doi.org\/10.2147\/OTT.S68084 (2014).","journal-title":"Onco. Targets Ther."},{"key":"98922_CR22","first-page":"1181","volume":"33","author":"H Nishikawa","year":"2013","unstructured":"Nishikawa, H. et al. Pre-treatment C-reactive protein as a prognostic factor for recurrence after surgical resection of hepatocellular carcinoma. Anticancer Res. 33, 1181\u20131188 (2013).","journal-title":"Anticancer Res."},{"key":"98922_CR23","doi-asserted-by":"publisher","first-page":"e0116909","DOI":"10.1371\/journal.pone.0116909","volume":"10","author":"X Zhao","year":"2015","unstructured":"Zhao, X., Luo, J., Li, B., Liu, S. & Li, D. The association between preoperative serum C-reactive protein and hepatocellular carcinoma recurrence in patients with chronic hepatitis B virus (HBV) infection\u2013a retrospective study. PLoS ONE 10, e0116909. https:\/\/doi.org\/10.1371\/journal.pone.0116909 (2015).","journal-title":"PLoS ONE"},{"key":"98922_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4149\/neo_2014_001","volume":"61","author":"X He","year":"2014","unstructured":"He, X., Wang, Y. & Zhang, W. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ-MALDI-MS\/MS. Neoplasma 61, 17\u201326 (2014).","journal-title":"Neoplasma"},{"key":"98922_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12094-012-0976-y","volume":"15","author":"N Imai","year":"2013","unstructured":"Imai, N. et al. Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma. Clin. Transl. Oncol. 15, 575\u2013581. https:\/\/doi.org\/10.1007\/s12094-012-0976-y (2013).","journal-title":"Clin. Transl. Oncol."},{"key":"98922_CR26","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/hep.26057","volume":"57","author":"W Sieghart","year":"2013","unstructured":"Sieghart, W. et al. Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma. Hepatology 57, 2224\u20132234. https:\/\/doi.org\/10.1002\/hep.26057 (2013).","journal-title":"Hepatology"},{"key":"98922_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12935-014-0104-x","volume":"14","author":"C Liu","year":"2014","unstructured":"Liu, C. et al. Interleukin-23A is associated with tumor growth in Helicobacter-pylori-related human gastric cancer. Cancer Cell Int. 14, 104. https:\/\/doi.org\/10.1186\/s12935-014-0104-x (2014).","journal-title":"Cancer Cell Int."},{"key":"98922_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000336913","volume":"30","author":"G Szabo","year":"2012","unstructured":"Szabo, G. & Lippai, D. Molecular hepatic carcinogenesis: impact of inflammation. Dig. Dis. 30, 243\u2013248. https:\/\/doi.org\/10.1159\/000336913 (2012).","journal-title":"Dig. Dis."},{"key":"98922_CR29","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.3390\/v6104047","volume":"6","author":"A Morales-S\u00e1nchez","year":"2014","unstructured":"Morales-S\u00e1nchez, A. & Fuentes-Panan\u00e1, E. M. Human viruses and cancer. Viruses 6, 4047\u20134079. https:\/\/doi.org\/10.3390\/v6104047 (2014).","journal-title":"Viruses"},{"key":"98922_CR30","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/cancers6042155","volume":"6","author":"Y Chen","year":"2014","unstructured":"Chen, Y., Williams, V., Filippova, M., Filippov, V. & Duerksen-Hughes, P. Viral carcinogenesis: Factors inducing DNA damage and virus integration. Cancers (Basel) 6, 2155\u20132186. https:\/\/doi.org\/10.3390\/cancers6042155 (2014).","journal-title":"Cancers (Basel)"},{"key":"98922_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/ars.2011.4351","volume":"17","author":"JL Wallace","year":"2012","unstructured":"Wallace, J. L., Ferraz, J. G. & Muscara, M. N. Hydrogen sulfide: An endogenous mediator of resolution of inflammation and injury. Antioxid. Redox Signal. 17, 58\u201367. https:\/\/doi.org\/10.1089\/ars.2011.4351 (2012).","journal-title":"Antioxid. Redox Signal."},{"key":"98922_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11626-013-9659-4","volume":"49","author":"Y Zheng","year":"2013","unstructured":"Zheng, Y. et al. Lipopolysaccharide regulates biosynthesis of cystathionine \u03b3-lyase and hydrogen sulfide through Toll-like receptor-4\/p38 and Toll-like receptor-4\/NF-\u03baB pathways in macrophages. In Vitro Cell Dev. Biol. Anim. 49, 679\u2013688. https:\/\/doi.org\/10.1007\/s11626-013-9659-4 (2013).","journal-title":"In Vitro Cell Dev. Biol. Anim."},{"key":"98922_CR33","doi-asserted-by":"publisher","first-page":"848570","DOI":"10.1155\/2014\/848570","volume":"2014","author":"A Badiei","year":"2014","unstructured":"Badiei, A., Muniraj, N., Chambers, S. & Bhatia, M. Inhibition of hydrogen sulfide production by gene silencing attenuates inflammatory activity by downregulation of NF-\u03baB and MAP kinase activity in LPS-activated RAW 264.7 cells. Biomed. Res. Int. 2014, 848570. https:\/\/doi.org\/10.1155\/2014\/848570 (2014).","journal-title":"Biomed. Res. Int."},{"key":"98922_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/ars.2016.6773","volume":"27","author":"L Ci","year":"2017","unstructured":"Ci, L., Yang, X. & Gu, X. Cystathionine \u03b3-lyase deficiency exacerbates CCl(4)-induced acute hepatitis and fibrosis in the mouse liver. Antioxid. Redox Signal. 27, 133\u2013149 (2017).","journal-title":"Antioxid. Redox Signal."},{"key":"98922_CR35","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.freeradbiomed.2012.02.033","volume":"52","author":"H Yamada","year":"2012","unstructured":"Yamada, H. et al. Methionine excess in diet induces acute lethal hepatitis in mice lacking cystathionine \u03b3-lyase, an animal model of cystathioninuria. Free Radic. Biol. Med. 52, 1716\u20131726. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.02.033 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"98922_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mrfmmm.2014.03.002","volume":"763\u2013764","author":"Y Pan","year":"2014","unstructured":"Pan, Y. et al. Hydrogen sulfide (H2S)\/cystathionine \u03b3-lyase (CSE) pathway contributes to the proliferation of hepatoma cells. Mutat. Res. 763\u2013764, 10\u201318. https:\/\/doi.org\/10.1016\/j.mrfmmm.2014.03.002 (2014).","journal-title":"Mutat. Res."},{"key":"98922_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/liv.12749","volume":"35","author":"C Ferrari","year":"2015","unstructured":"Ferrari, C. HBV and the immune response. Liver Int. 35, 121\u2013128 (2015).","journal-title":"Liver Int."},{"key":"98922_CR38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","volume":"87","author":"A Bertoletti","year":"2006","unstructured":"Bertoletti, A. & Gehring, A. J. The immune response during hepatitis B virus infection. J. Gen. Virol. 87, 1439\u20131449. https:\/\/doi.org\/10.1099\/vir.0.81920-0 (2006).","journal-title":"J. Gen. Virol."},{"key":"98922_CR39","first-page":"97","volume":"3","author":"CF Huang","year":"2006","unstructured":"Huang, C. F., Lin, S. S., Ho, Y. C., Chen, F. L. & Yang, C. The immune response induced by hepatitis B virus principal antigens. Cell Mol. Immunol. 3, 97\u2013106 (2006).","journal-title":"Cell Mol. Immunol."},{"key":"98922_CR40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1440-1746.2008.05385.x","volume":"23","author":"AT Tan","year":"2008","unstructured":"Tan, A. T., Koh, S. & Goh, V. Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective. J. Gastroenterol. Hepatol. 23, 833\u2013843. https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05385.x (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"98922_CR41","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem, D. & Prince, A. M. Hepatitis B virus infection\u2013natural history and clinical consequences. N. Engl. J. Med. 350, 1118\u20131129. https:\/\/doi.org\/10.1056\/NEJMra031087 (2004).","journal-title":"N. Engl. J. Med."},{"key":"98922_CR42","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/hep.20956","volume":"43","author":"HJ Yim","year":"2006","unstructured":"Yim, H. J. & Lok, A. S. Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005. Hepatology 43, S173-181. https:\/\/doi.org\/10.1002\/hep.20956 (2006).","journal-title":"Hepatology"},{"key":"98922_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2188\/jea.je20100190","volume":"21","author":"M Tanaka","year":"2011","unstructured":"Tanaka, M. et al. Hepatitis B and C virus infection and hepatocellular carcinoma in China: A review of epidemiology and control measures. J. Epidemiol. 21, 401\u2013416. https:\/\/doi.org\/10.2188\/jea.je20100190 (2011).","journal-title":"J. Epidemiol."},{"key":"98922_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cmi.2011.53","volume":"9","author":"R Xu","year":"2012","unstructured":"Xu, R., Zhang, Z. & Wang, F. S. Liver fibrosis: Mechanisms of immune-mediated liver injury. Cell Mol. Immunol. 9, 296\u2013301. https:\/\/doi.org\/10.1038\/cmi.2011.53 (2012).","journal-title":"Cell Mol. Immunol."},{"key":"98922_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.14218\/JCTH.2015.00024","volume":"3","author":"T Lan","year":"2015","unstructured":"Lan, T., Chang, L., Wu, L. & Yuan, Y. F. IL-6 plays a crucial role in HBV infection. J. Clin. Transl. Hepatol. 3, 271\u2013276. https:\/\/doi.org\/10.14218\/JCTH.2015.00024 (2015).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"98922_CR46","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/v12080864","volume":"12","author":"CL Vinhaes","year":"2020","unstructured":"Vinhaes, C. L. et al. Chronic hepatitis B infection is associated with increased molecular degree of inflammatory perturbation in peripheral blood. Viruses 12, 864. https:\/\/doi.org\/10.3390\/v12080864 (2020).","journal-title":"Viruses"},{"key":"98922_CR47","first-page":"432","volume":"47","author":"S Hao","year":"2017","unstructured":"Hao, S., Wang, Y., Gao, G. & Li, Z. Hepatitis B virus upregulates the expression of C-reactive protein both in vivo and in vitro. Ann. Clin. Lab. Sci. 47, 432\u2013435 (2017).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"98922_CR48","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black, S., Kushner, I. & Samols, D. C-reactive protein. J. Biol. Chem. 279, 48487\u201348490. https:\/\/doi.org\/10.1074\/jbc.R400025200 (2004).","journal-title":"J. Biol. Chem."},{"key":"98922_CR49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.molimm.2004.09.028","volume":"42","author":"A Agrawal","year":"2005","unstructured":"Agrawal, A. CRP after 2004. Mol. Immunol. 42, 927\u2013930 (2005).","journal-title":"Mol. Immunol."},{"key":"98922_CR50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-024-07098-5","volume":"627","author":"AG York","year":"2024","unstructured":"York, A. G. et al. IL-10 constrains sphingolipid metabolism to limit inflammation. Nature 627, 628\u2013635. https:\/\/doi.org\/10.1038\/s41586-024-07098-5 (2024).","journal-title":"Nature"},{"key":"98922_CR51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/jmv.27327","volume":"94","author":"K Yao","year":"2022","unstructured":"Yao, K. et al. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA. J. Med. Virol. 94, 659\u2013666. https:\/\/doi.org\/10.1002\/jmv.27327 (2022).","journal-title":"J. Med. Virol."},{"key":"98922_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2753.2010.01599.x","volume":"18","author":"M Patel","year":"2012","unstructured":"Patel, M. et al. Hepatocellular carcinoma: Diagnostics and screening. J. Eval. Clin. Pract. 18, 335\u2013342. https:\/\/doi.org\/10.1111\/j.1365-2753.2010.01599.x (2012).","journal-title":"J. Eval. Clin. Pract."},{"key":"98922_CR53","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/egh.09.35","volume":"3","author":"MI Shariff","year":"2009","unstructured":"Shariff, M. I. et al. Hepatocellular carcinoma: Current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev. Gastroenterol Hepatol. 3, 353\u2013367. https:\/\/doi.org\/10.1586\/egh.09.35 (2009).","journal-title":"Expert Rev. Gastroenterol Hepatol."},{"key":"98922_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1470-2045(12)70233-4","volume":"13","author":"Q Shen","year":"2012","unstructured":"Shen, Q. et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre study. Lancet Oncol. 13, 817\u2013826. https:\/\/doi.org\/10.1016\/S1470-2045(12)70233-4 (2012).","journal-title":"Lancet Oncol."},{"key":"98922_CR55","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1158\/1055-9965.EPI-14-1038","volume":"24","author":"W Chen","year":"2015","unstructured":"Chen, W. et al. Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian nutrition intervention trials: A nested case-control study. Cancer Epidemiol. Biomark. Prev. 24, 386\u2013392. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-1038 (2015).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"98922_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/s-0034-1394139","volume":"34","author":"M Sherman","year":"2014","unstructured":"Sherman, M. & Colombo, M. Hepatocellular carcinoma screening and diagnosis. Semin. Liver Dis. 34, 389\u2013397. https:\/\/doi.org\/10.1055\/s-0034-1394139 (2014).","journal-title":"Semin. Liver Dis."},{"key":"98922_CR57","doi-asserted-by":"publisher","first-page":"102773","DOI":"10.1016\/j.redox.2023.102773","volume":"64","author":"M Peleli","year":"2023","unstructured":"Peleli, M. et al. Cystathionine gamma-lyase (CTH) inhibition attenuates glioblastoma formation. Redox Biol. 64, 102773. https:\/\/doi.org\/10.1016\/j.redox.2023.102773 (2023).","journal-title":"Redox Biol."},{"key":"98922_CR58","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/00000658-200004000-00015","volume":"231","author":"GY Chau","year":"2000","unstructured":"Chau, G. Y. et al. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann. Surg. 231, 552\u2013558. https:\/\/doi.org\/10.1097\/00000658-200004000-00015 (2000).","journal-title":"Ann. Surg."},{"key":"98922_CR59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1478-3231.2004.00882.x","volume":"27","author":"E Hattori","year":"2003","unstructured":"Hattori, E. et al. Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma. Hepatol. Res. 27, 309\u2013314. https:\/\/doi.org\/10.1111\/j.1478-3231.2004.00882.x (2003).","journal-title":"Hepatol. Res."},{"key":"98922_CR60","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1002\/cncr.26726","volume":"118","author":"SL Chan","year":"2012","unstructured":"Chan, S. L. et al. A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma. Cancer 118, 3984\u20133992. https:\/\/doi.org\/10.1002\/cncr.26726 (2012).","journal-title":"Cancer"},{"key":"98922_CR61","doi-asserted-by":"publisher","first-page":"5202898","DOI":"10.1155\/2022\/5202898","volume":"2022","author":"Z Su","year":"2022","unstructured":"Su, Z. et al. Circulating IL-1\u03b2, IL-17, and IP-10 as potential predictors of hepatitis b virus infection prognosis. J. Immunol. Res. 2022, 5202898. https:\/\/doi.org\/10.1155\/2022\/5202898 (2022).","journal-title":"J. Immunol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98922-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98922-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98922-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:39:49Z","timestamp":1747906789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98922-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98922"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98922-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was conducted in Guangxi Province on October 14, 2024, and approved by the Medical Ethics Committee of the First Affiliated Hospital of Medical University (Lot No.: 2024-E726-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"17777"}}